Interleukin-5, eosinophils, and disease.
暂无分享,去创建一个
[1] M. Strath,et al. Infection of IL5 transgenic mice with Mesocestoides corti induces very high levels of IL5 but depressed production of eosinophils. , 1992, Experimental hematology.
[2] A. Marchevsky,et al. Vascular rejection and graft eosinophilia in rat lung allografts. , 1991, The Journal of surgical research.
[3] V. Brusasco,et al. Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. , 1991, The American review of respiratory disease.
[4] T. Suda,et al. In vivo changes of hemopoietic progenitors and the expression of the interleukin 5 gene in eosinophilic mice infected with Toxocara canis. , 1990, Experimental hematology.
[5] H. Saito,et al. CONSTITUTIVE GENE EXPRESSION OF INTERLEUKIN‐5 IN KIMURA'S DISEASE , 1990, British journal of haematology.
[6] J. Hoidal. The eosinophil and acute lung injury. , 1990, The American review of respiratory disease.
[7] R. Folkerth,et al. Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[9] H. Enokihara,et al. Interleultin‐2 treatment‐associated eosinophilia is mediated by interleultin‐5 production , 1990 .
[10] A. Wardlaw,et al. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. , 1990, Immunology.
[11] A. Limaye,et al. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients , 1990, The Journal of experimental medicine.
[12] B. Vogelstein,et al. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response , 1990, Cell.
[13] C. Wegner,et al. Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. , 1990, Journal of applied physiology.
[14] R. Rothlein,et al. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.
[15] M. Samoszuk,et al. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. , 1990, Blood.
[16] A. Sheffer,et al. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome , 1989, The Journal of experimental medicine.
[17] P. Leder,et al. Murine interleukin-4 displays potent anti-tumor activity in vivo , 1989, Cell.
[18] R. Lang,et al. Nonneoplastic hematopoietic myeloproliferative syndrome induced by dysregulated multi-CSF (IL-3) expression. , 1989, Blood.
[19] Ji Ming Wang,et al. Recombinant human interleukin 5 is a selective eosinophil chemoattractant , 1989, European journal of immunology.
[20] I. Hariharan,et al. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte‐macrophage colony stimulating factor. , 1989, The EMBO journal.
[21] S. Ackerman. The new gestalt: asthma as a chronic inflammatory disease. , 1989, The Journal of asthma : official journal of the Association for the Care of Asthma.
[22] A. B. Kay,et al. Inflammatory cells in bronchial asthma. , 1989, The Journal of asthma : official journal of the Association for the Care of Asthma.
[23] D. Metcalf,et al. Divergent disease patterns in granulocyte-macrophage colony-stimulating factor transgenic mice associated with different transgene insertion sites. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[24] W. Amend,et al. THE IMPORTANCE OF EOSINOPHIL CELLS IN KIDNEY ALLOGRAFT REJECTION , 1988, Transplantation.
[25] R. Cuthbertson,et al. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage , 1987, Cell.
[26] K. Maclennan,et al. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation. , 1987, Journal of clinical pathology.
[27] R. Callard,et al. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays , 1987, European journal of immunology.
[28] B. Nathwani,et al. Extensive deposition of eosinophil peroxidase in Hodgkin's and non-Hodgkin's lymphomas. , 1986, The American journal of pathology.
[29] T. Fujimura,et al. Malignant tumor and eosinophils: I. Prognostic significance in gastric cancer , 1986, Cancer.
[30] M. Hall-Craggs,et al. The prognostic value of the eosinophil in acute renal allograft rejection. , 1986, Transplantation.
[31] G. Gleich,et al. The eosinophilic leukocyte: structure and function. , 1986, Advances in immunology.
[32] U. Blumenthal,et al. Eosinophilia and resistance to Schistosoma haematobium in man , 1985, Parasite immunology.
[33] P. Häyry,et al. BLOOD EOSINOPHILIA, STEROIDS, AND REJECTION , 1985, Transplantation.
[34] H. Sluiter,et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. , 1985, The American review of respiratory disease.
[35] P. Kallós,et al. Experimental asthma in guinea pigs revisited. , 1984, International archives of allergy and applied immunology.
[36] P. Jansa,et al. Local eosinophilia in stroma of tumors related to prognosis. , 1984, Neoplasma.
[37] T. P. Pretlow,et al. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. , 1983, Cancer research.
[38] R. Sturrock,et al. Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[39] D. Lowe,et al. Tumour-associated eosinophilia: a review. , 1981, Journal of clinical pathology.
[40] F. Muggia,et al. Radiation-related eosinophilia. Correlation with delayed hypersensitivity, lymphocyte count, and survival in patients treated by curative radiotherapy. , 1975, Radiology.